BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 18308464)

  • 1. The role of endocannabinoids in the regulation of luteinizing hormone and prolactin release. Differences between the effects of AEA and 2AG.
    Oláh M; Milloh H; Wenger T
    Mol Cell Endocrinol; 2008 Apr; 286(1-2 Suppl 1):S36-40. PubMed ID: 18308464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics.
    Fernández-Ruiz JJ; Muñoz RM; Romero J; Villanua MA; Makriyannis A; Ramos JA
    Biochem Pharmacol; 1997 Jun; 53(12):1919-27. PubMed ID: 9256167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamus-pituitary axis: an obligatory target for endocannabinoids to inhibit steroidogenesis in frog testis.
    Chianese R; Ciaramella V; Fasano S; Pierantoni R; Meccariello R
    Gen Comp Endocrinol; 2014 Sep; 205():88-93. PubMed ID: 24566122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endogenous cannabinoid, anandamide, activates the hypothalamo-pituitary-adrenal axis in CB1 cannabinoid receptor knockout mice.
    Wenger T; Ledent C; Tramu G
    Neuroendocrinology; 2003 Dec; 78(6):294-300. PubMed ID: 14688442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum.
    Maccarrone M; Rossi S; Bari M; De Chiara V; Fezza F; Musella A; Gasperi V; Prosperetti C; Bernardi G; Finazzi-Agrò A; Cravatt BF; Centonze D
    Nat Neurosci; 2008 Feb; 11(2):152-9. PubMed ID: 18204441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibitory effect of anandamide on luteinizing hormone-releasing hormone secretion is reversed by estrogen.
    Scorticati C; Fernández-Solari J; De Laurentiis A; Mohn C; Prestifilippo JP; Lasaga M; Seilicovich A; Billi S; Franchi A; McCann SM; Rettori V
    Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11891-6. PubMed ID: 15280536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Membrane cholesterol mediates the endocannabinoids-anandamide affection on HepG2 cells].
    Wu WJ; Yang Q; Cao QF; Zhang YW; Xia YJ; Hu XW; Tang WX
    Zhonghua Gan Zang Bing Za Zhi; 2010 Mar; 18(3):204-8. PubMed ID: 20380798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of anandamide on prolactin secretion is modulated by estrogen.
    Scorticati C; Mohn C; De Laurentiis A; Vissio P; Fernández Solari J; Seilicovich A; McCann SM; Rettori V
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):2134-9. PubMed ID: 12578974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anandamide capacitates bull spermatozoa through CB1 and TRPV1 activation.
    Gervasi MG; Osycka-Salut C; Caballero J; Vazquez-Levin M; Pereyra E; Billi S; Franchi A; Perez-Martinez S
    PLoS One; 2011 Feb; 6(2):e16993. PubMed ID: 21347292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential role of CB1 and TRPV1 receptors on anandamide modulation of defensive responses induced by nitric oxide in the dorsolateral periaqueductal gray.
    Lisboa SF; Guimarães FS
    Neuropharmacology; 2012 Jun; 62(8):2455-62. PubMed ID: 22394688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anandamide inhibits the growth of colorectal cancer cells through CB1 and lipid rafts].
    Liao YS; Wu J; Wang P; Zhang H
    Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):256-9. PubMed ID: 21575494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiangiogenic activity of the endocannabinoid anandamide: correlation to its tumor-suppressor efficacy.
    Pisanti S; Borselli C; Oliviero O; Laezza C; Gazzerro P; Bifulco M
    J Cell Physiol; 2007 May; 211(2):495-503. PubMed ID: 17192847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High levels of anandamide, an endogenous cannabinoid, block the growth of sheep preimplantation embryos by inducing apoptosis and reversible arrest of cell proliferation.
    Turco MY; Matsukawa K; Czernik M; Gasperi V; Battista N; Della Salda L; Scapolo PA; Loi P; Maccarrone M; Ptak G
    Hum Reprod; 2008 Oct; 23(10):2331-8. PubMed ID: 18614613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.
    Melck D; De Petrocellis L; Orlando P; Bisogno T; Laezza C; Bifulco M; Di Marzo V
    Endocrinology; 2000 Jan; 141(1):118-26. PubMed ID: 10614630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocannabinoids stimulate human melanogenesis via type-1 cannabinoid receptor.
    Pucci M; Pasquariello N; Battista N; Di Tommaso M; Rapino C; Fezza F; Zuccolo M; Jourdain R; Finazzi Agrò A; Breton L; Maccarrone M
    J Biol Chem; 2012 May; 287(19):15466-78. PubMed ID: 22431736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcohol inhibits luteinizing hormone-releasing hormone release by activating the endocannabinoid system.
    Fernández-Solari J; Scorticati C; Mohn C; De Laurentiis A; Billi S; Franchi A; McCann SM; Rettori V
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3264-8. PubMed ID: 14981261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual effect of anandamide on rat placenta nitric oxide synthesis.
    Cella M; Leguizamón GF; Sordelli MS; Cervini M; Guadagnoli T; Ribeiro ML; Franchi AM; Farina MG
    Placenta; 2008 Aug; 29(8):699-707. PubMed ID: 18561998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous UPLC-MS/MS quantification of the endocannabinoids 2-arachidonoyl glycerol (2AG), 1-arachidonoyl glycerol (1AG), and anandamide in human plasma: minimization of matrix-effects, 2AG/1AG isomerization and degradation by toluene solvent extraction.
    Zoerner AA; Batkai S; Suchy MT; Gutzki FM; Engeli S; Jordan J; Tsikas D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 883-884():161-71. PubMed ID: 21752730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic exposure of sensory neurones to increased levels of nerve growth factor modulates CB1/TRPV1 receptor crosstalk.
    Evans RM; Scott RH; Ross RA
    Br J Pharmacol; 2007 Oct; 152(3):404-13. PubMed ID: 17700720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anandamide modulates the neuroendocrine responses induced by extracellular volume expansion.
    Ruginsk SG; Uchoa ET; Elias LL; Antunes-Rodrigues J
    Clin Exp Pharmacol Physiol; 2013 Oct; 40(10):698-705. PubMed ID: 23875874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.